Literature DB >> 23636662

How much should the NHS pay for a QALY?

Alan Haycox.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23636662     DOI: 10.1007/s40273-013-0062-5

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  3 in total

1.  Should NICE's threshold range for cost per QALY be raised? Yes.

Authors:  Adrian Towse
Journal:  BMJ       Date:  2009-01-26

2.  Should NICE's threshold range for cost per QALY be raised? No.

Authors:  James Raftery
Journal:  BMJ       Date:  2009-01-26

3.  The determinants of cost-effectiveness potential: an historical perspective on lipid-lowering therapies.

Authors:  Rodrigo Refoios Camejo; Clare McGrath; Marisa Miraldo; Frans Rutten
Journal:  Pharmacoeconomics       Date:  2013-05       Impact factor: 4.981

  3 in total
  3 in total

1.  The Irish Cost-Effectiveness Threshold: Does it Support Rational Rationing or Might it Lead to Unintended Harm to Ireland's Health System?

Authors:  James F O'Mahony; Diarmuid Coughlan
Journal:  Pharmacoeconomics       Date:  2016-01       Impact factor: 4.981

2.  e-CBT (myCompass), Antidepressant Medication, and Face-to-Face Psychological Treatment for Depression in Australia: A Cost-Effectiveness Comparison.

Authors:  Daniela Solomon; Judith Proudfoot; Janine Clarke; Helen Christensen
Journal:  J Med Internet Res       Date:  2015-11-11       Impact factor: 5.428

3.  Why Cancer?

Authors:  Alan Haycox
Journal:  Pharmacoeconomics       Date:  2016-07       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.